Recommandations en Rhumatologie
50 recommandations en vigueur en Rhumatologie émanant d’agences nationales, de sociétés savantes européennes et d’organismes d’HTA, réparties sur 11 groupes de sources. eUvidence ancre ses réponses en Rhumatologie sur ces recommandations ; chaque entrée renvoie à la page de l’organisme émetteur.
Sociétés savantes européennes· 13
- EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
EULAR · European Alliance of Associations for Rheumatology · 2025 · recommendation
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
EULAR · European Alliance of Associations for Rheumatology · 2024 · recommendation
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
EULAR · European Alliance of Associations for Rheumatology · 2024 · recommendation
- EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
EULAR · European Alliance of Associations for Rheumatology · 2024 · recommendation
- EULAR recommendations for the treatment of systemic sclerosis: 2023 update
EULAR · European Alliance of Associations for Rheumatology · 2024 · recommendation
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
EULAR · European Alliance of Associations for Rheumatology · 2023 · recommendation
- ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
EULAR · European Alliance of Associations for Rheumatology · 2023 · recommendation
- EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies
EULAR · European Alliance of Associations for Rheumatology · 2020 · recommendation
- 2018 Update of the EULAR recommendations for the management of large vessel vasculitis
EULAR · European Alliance of Associations for Rheumatology · 2020 · recommendation
- EULAR recommendations for the management of antiphospholipid syndrome in adults
EULAR · European Alliance of Associations for Rheumatology · 2019 · recommendation
- 2018 update of the EULAR recommendations for the management of hand osteoarthritis
EULAR · European Alliance of Associations for Rheumatology · 2019 · recommendation
- 2016 updated EULAR evidence-based recommendations for the management of gout
EULAR · European Alliance of Associations for Rheumatology · 2017 · recommendation
- 2015 Recommendations for the management of polymyalgia rheumatica: a EULAR/ACR collaborative initiative
EULAR · European Alliance of Associations for Rheumatology · 2015 · recommendation
Autriche· 1
- Osteoporosis - definition, risk assessment, diagnosis, prevention and treatment (Update 2024)
OEGKM · Osterreichische Gesellschaft fuer Knochen- und Mineralstoffwechsel · 2024
Danemark· 1
- Osteoporosis in Postmenopausal Women and Men Over 60 in General Practice
DSAM · Dansk Selskab for Almen Medicin · 2024
Finlande· 1
- Rheumatoid Arthritis (RA)
Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Society for Rheumatology · 2015
France· 6
- 2024 Update of the French Society for Rheumatology Recommendations for the Diagnosis and Management of People with Rheumatoid Arthritis
SFR · Societe Francaise de Rhumatologie · 2024 · recommendation
- French Society for Rheumatology Recommendations for the Everyday Management of Patients with Polymyalgia Rheumatica
SFR · Societe Francaise de Rhumatologie · 2024 · recommendation
- 2022 Update of the SFR Recommendations for the Everyday Management of Patients with Spondyloarthritis, Including Psoriatic Arthritis
SFR · Societe Francaise de Rhumatologie · 2022 · recommendation
- French Recommendations for the Management and Treatment of Male Osteoporosis
SFR · Societe Francaise de Rhumatologie · 2021 · recommendation
- French Society for Rheumatology Recommendations for the Management of Gout: Urate-Lowering Therapy
SFR · Societe Francaise de Rhumatologie · 2020 · recommendation
- 2018 Update of French Recommendations for the Treatment of Postmenopausal Osteoporosis
SFR · Societe Francaise de Rhumatologie · 2018 · recommendation
Allemagne· 7
- Management of Systemic Lupus Erythematosus (incl. Secondary Antiphospholipid Syndrome, Family Planning and Pregnancy)
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2025
- Treatment of Polymyalgia Rheumatica (Update 2024)
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2025
- Diagnosis and Treatment of Systemic Sclerosis
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2025
- Diagnosis and Treatment of Gout
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2024
- Diagnosis and Treatment of ANCA-Associated Vasculitides
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2024
- Diagnosis and Treatment of Adult-Onset Still's Disease
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2023
- Axial Spondyloarthritis including Ankylosing Spondylitis and Early Forms
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2019
Italie· 1
- Diagnosis and Treatment of Large-Vessel Vasculitis
SIR · Societa Italiana di Reumatologia · 2021
Pays-Bas· 7
- Rheumatoid Arthritis
FMS · Federatie Medisch Specialisten · 2026
- Treatment of Axial Spondyloarthritis
FMS · Federatie Medisch Specialisten · 2025
- Pharmacological Treatment of Psoriatic Arthritis
FMS · Federatie Medisch Specialisten · 2024
- Diagnosis and Treatment of Gout in Secondary Care
FMS · Federatie Medisch Specialisten · 2024
- Pharmacological Treatment and Monitoring of Systemic Lupus Erythematosus
FMS · Federatie Medisch Specialisten · 2023
- Osteoporosis and Fracture Prevention
FMS · Federatie Medisch Specialisten · 2022
- Conservative Treatment of Osteoarthritis of the Hip or Knee
FMS · Federatie Medisch Specialisten · 2019
Espagne· 3
- Clinical Practice Guideline for the Management of Patients with Rheumatoid Arthritis
SER · Sociedad Espanola de Reumatologia · 2025
- Clinical Practice Guideline for the Treatment of Axial Spondyloarthritis and Psoriatic Arthritis (ESPOGUIA)
SER · Sociedad Espanola de Reumatologia · 2025
- Clinical Practice Guidelines on Postmenopausal, Glucocorticoid-Induced and Male Osteoporosis (2022 Update)
SEIOMM · Sociedad Espanola de Investigacion Osea y del Metabolismo Mineral · 2022
Suède· 1
- National Guidelines for Musculoskeletal Diseases - Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Osteoarthritis and Osteoporosis - Support for Governance and Management
Socialstyrelsen · National Board of Health and Welfare · 2021
Royaume-Uni· 9
- The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs
BSR · British Society for Rheumatology · 2025
- Osteoarthritis in over 16s: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2022
- Gout: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2022
- Rheumatoid arthritis in adults: management
NICE · National Institute for Health and Care Excellence · 2020
- British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis
BSR · British Society for Rheumatology · 2020
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
BSR · British Society for Rheumatology · 2018
- Spondyloarthritis in over 16s: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2017
- Osteoporosis: assessing the risk of fragility fracture
NICE · National Institute for Health and Care Excellence · 2017
- BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs
BSR · British Society for Rheumatology · 2017
Vous cherchez un pays en particulier ? Autriche, Danemark, Finlande, France, Allemagne, Italie.